Susan G. Komen reports that it supports breast cancer research, patient care, and advocacy. The organization distributes grants to research institutions and other non-profit organizations that focus research projects on the biology of breast cancer; new strategies to treat, detect, and predict risk of breast cancer; and addressing disparities in outcomes. Susan G. Komen also distributes grants to other non-profits for the provision of breast cancer screening, diagnosis, and treatment programs. Some ($25,433,425 or 23%) of Susan G. Komen's programs are conducted in conjunction with informational materials that include fundraising appeals.
For the year ended March 31, 2021, Susan G. Komen's program expenses were:
Education and patient services |
$84,193,870 |
Research |
$17,341,573 |
Health screening services |
$5,593,895 |
Treatment services |
$4,237,315 |
Total Program Expenses: |
$111,366,653 |
-
Chief Executive
Paula Schneider, President and Chief Executive Officer
-
Compensation*
$553,557
-
Chair of the Board
Ed Dandridge
-
Chair's Profession / Business Affiliation
Senior Vice President of Communications, The Boeing Company
-
Board Size
16
-
Paid Staff Size
314
*2020 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Telephone appeals, Radio, Cause- related marketing (affinity credit cards, consumer product sales, etc.), Television
Susan G. Komen incurred joint costs of $44,954,538 for informational materials and activities that included fundraising materials. Of those costs $25,433,425 was allocated to program expenses, $13,118,234 was allocated to fundraising expenses, and $6,402,879 was allocated to administrative expenses.
Fundraising costs were 15% of related contributions. (Related contributions, which totaled $127,419,756 are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Susan G. Komen's audited financial statements - consolidated for the year ended March 31, 2021.
Source of Funds |
Contributions, net |
$75,139,119 |
In-kind contributions |
$49,747,305 |
Investments, net |
$6,322,035 |
CARES Act income |
$2,533,602 |
Interest and dividends |
$1,313,529 |
Other income |
$186,300 |
Total Income |
$135,241,890 |
- Programs: 69%
- Administrative: 20%
- Fundraising: 11%
Total Income |
$135,241,890 |
Program expenses |
$111,366,653 |
Fundraising expenses |
$18,623,264 |
Administrative expenses |
$32,402,442 |
Other expenses |
$0 |
Total expenses: |
$162,392,359 |
Income in Excess of Expenses |
$-27,150,469 |
Beginning Net Assets |
$152,803,291 |
Other Changes In Net Assets |
$20,304,093 |
Ending Net Assets |
$145,956,915 |
Total Liabilities |
$57,765,090 |
Total Assets |
$203,722,005 |
Note 1: As noted in the above financial section, "other changes in net assets" refers to a change in net unrealized gains on investments.
Note 2: According to Susan G. Komen's audited financial statements - consolidated - for the year ended March 31, 2021, the organization received $49,747,305 in donated local television, radio, and newspaper advertising.